Fundraising Fox

Nick Whitehead

Founder

CEO, CSO & Co-Founder at Myosana Therapeutics

Seattle, Washington, United States

FoundedMyosana Therapeutics

Find your path to Nick

170 people in our graph share verified history with Nick β€” schools, employers, funds. One of them is your warm intro.

Paul JennyunlockedNick: together at University of Washington (2009–2016)
Γ—5Nick: together at University of Washington
Γ—6Nick: together at Monash University

About

Nick Whitehead is Co-Founder and CEO of Myosana Therapeutics and inventor of the company's non-viral gene delivery platform. He has worked in muscle physiology and Duchenne muscular dystrophy research for over 20 years.

CEO, CSO & Co-Founder at Myosana Therapeutics

Co-founders at Myosana Therapeutics

SFStan Froehner
Stan FroehnerCFO, Chairman, and Co-Founder

Experience

  1. Myosana TherapeuticsCo-Founder and CEOcurrent2018 β€” presentSeattle, Washington, United States
  2. University of WashingtonResearch Associate Professorcurrent2009 β€” presentSeattle, Washington, United States
  3. University of SydneyPostdoctoral Researcher2002 β€” 2009Sydney, Australia

Skills & more

Research6Scientific Writing6Data Analysis4

From Nick's professional profile.

Frequently asked questions

Who is Nick Whitehead?
Nick Whitehead is Co-Founder and CEO of Myosana Therapeutics and inventor of the company's non-viral gene delivery platform. He has worked in muscle physiology and Duchenne muscular dystrophy research for over 20 years.
Where does Nick Whitehead work?
Nick Whitehead is CEO, CSO & Co-Founder of Myosana Therapeutics.
What companies did Nick Whitehead found?
Nick Whitehead founded Myosana Therapeutics.
Where did Nick Whitehead go to school?
Nick Whitehead studied at Monash University (Doctor of Philosophy - PhD, Muscle Physiology); Monash University (Bachelor of Science - BS).

Founder mafias

Same school

Shared employers